The 120-page report with TOC analyzes the ear infection treatment market by type (middle ear infections, outer ear infections, and inner ear infections) and geography (North America, Europe, Asia, and Rest of World (ROW)).
The ear infection treatment market is driven by the high-risk factors for ear infections. In addition, rising funding for research on ear infections is anticipated to boost the growth of the ear infection treatment market.
Ear infections mainly affect the ear canal, the middle ear, or the inner ear. These infections are caused due to various risk factors such as bacteria, viral cold or flu, injury to the ear, or smoking. According to a study, nearly 40 million adults in the US smoke cigarettes, and about 4.7 million middle and high school students use at least one tobacco product, including e-cigarettes. This is increasing the prevalence of various diseases including lung diseases and ear infections. Similarly, on average, adults have 2 to 3 colds per year, and children have even more. Such high-risk factors are increasing the incidence of ear infections, thereby driving the growth of the ear infection treatment market.
Major Ear Infection Treatment Market Players:
The global ear infection treatment market is fragmented with the presence of leading and well-established pharmaceutical players. The market is likely to witness slight vendor dilution with the increasing popularity of antibiotics and various other symptomatic treatment options. Currently, the market does not have a strong pipeline as the available therapeutics are used for symptomatic treatment only. Hence, companies focus on R&D to meet the unmet need, which will further intensify the competition among them. The following are identified as the dominant players in the market.
- Akorn Inc.
- Aurobindo Pharma Ltd.
- Biovea
- Zydus Lifesciences Ltd.
- Fresenius SE and Co. KGaA
- GlaxoSmithKline Plc
- Hyland
- Johnson and Johnson
- Lupin Ltd.
- Merck and Co. Inc.
- Mylan NV
- Novartis AG
- Otonomy Inc.
- Perrigo Co. Plc
- Sensorion
- Sun Pharmaceutical Industries Ltd.
- Wockhardt Ltd.
- WraSer Pharmaceuticals
- Pfizer Inc.
- F. Hoffmann La Roche Ltd.
Know about other key driving factors and dominant players in the market. Request a Free Sample Report
Ear Infection Treatment Market Type Outlook (Revenue, USD billion, 2021-2026)
- Middle ear infections - size and forecast 2021-2026
- Outer ear infections - size and forecast 2021-2026
- Inner ear infections - size and forecast 2021-2026
The market observed maximum growth in the middle ear infections segment in 2021. The high prevalence of AOM infection is one of the major drivers for the segment. In addition, extensive R&D efforts by vendors to launch new drugs are also driving the growth of the segment. The market growth in the segment will be significant during the forecast period.
Ear Infection Treatment Market Geography Outlook (Revenue, USD billion, 2021-2026)
- North America - size and forecast 2021-2026
- Europe - size and forecast 2021-2026
- Asia - size and forecast 2021-2026
- Rest of World (ROW) - size and forecast 2021-2026
North America will have the largest share of the market. The region currently holds 37% of the global market share. The availability of improved ear infection treatment options such as developed surgical treatment and diagnostics tools has been crucial in driving the growth of the ear infection treatment market in North America. The US and Canada are the key markets for ear infection treatment in North America. Countries such as Denmark, China, and India will also emerge as major markets for ear infection treatment during the forecast period.
Identify other revenue-generating segments, regions, and countries in the market.
Download a Free Sample Report
Related Reports:
Middle Ear Implants Market by Product, Application, and Geography - Forecast and Analysis 2022-2026
ENT Devices Market by Product and Geography - Forecast and Analysis 2021-2025
Ear Infection Treatment Market Scope |
Report Coverage |
Details |
Page number |
120 |
Base year |
2021 |
Forecast period |
2022-2026 |
Growth momentum & CAGR |
Accelerate at a CAGR of 5.44% |
Market growth 2022-2026 |
USD 3.67 billion |
Market structure |
Fragmented |
YoY growth (%) |
4.29 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 37% |
Key consumer countries |
US, Canada, Denmark, China, and India |
Competitive landscape |
Leading companies, competitive strategies, consumer engagement scope |
Companies profiled |
Akorn Inc., Aurobindo Pharma Ltd., Biovea, Zydus Lifesciences Ltd., Fresenius SE and Co. KGaA, GlaxoSmithKline Plc, Hyland, Johnson and Johnson, Lupin Ltd., Merck and Co. Inc., Mylan NV, Novartis AG, Otonomy Inc., Perrigo Co. Plc, Sensorion, Sun Pharmaceutical Industries Ltd., Wockhardt Ltd., WraSer Pharmaceuticals, Pfizer Inc., and F. Hoffmann La Roche Ltd. |
Market Dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Table of Contents:
1 Executive Summary
- 1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
- Exhibit 06: Executive Summary – Chart on Incremental Growth
- Exhibit 07: Executive Summary – Data Table on Incremental Growth
- Exhibit 08: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 09: Parent market
- Exhibit 10: Market Characteristics
3 Market Sizing
- 3.1 Market definition
- Exhibit 11: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 12: Market segments
- 3.4 Market outlook: Forecast for 2021-2026
- Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
- Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
- 4.1 Five forces summary
- Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
- 4.2 Bargaining power of buyers
- Exhibit 18: Bargaining power of buyers – Impact of key factors in 2021 and 2026
- 4.3 Bargaining power of suppliers
- Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
- 4.4 Threat of new entrants
- Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
- 4.5 Threat of substitutes
- Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
- 4.6 Threat of rivalry
- Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
- 4.7 Market condition
- Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by Type
- 5.1 Market segments
- Exhibit 24: Chart on Type - Market share 2021-2026 (%)
- Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
- 5.2 Comparison by Type
- Exhibit 26: Chart on Comparison by Type
- Exhibit 27: Data Table on Comparison by Type
- 5.3 Middle ear infections - Market size and forecast 2021-2026
- Exhibit 28: Chart on Middle ear infections - Market size and forecast 2021-2026 ($ million)
- Exhibit 29: Data Table on Middle ear infections - Market size and forecast 2021-2026 ($ million)
- Exhibit 30: Chart on Middle ear infections - Year-over-year growth 2021-2026 (%)
- Exhibit 31: Data Table on Middle ear infections - Year-over-year growth 2021-2026 (%)
- 5.4 Outer ear infections - Market size and forecast 2021-2026
- Exhibit 32: Chart on Outer ear infections - Market size and forecast 2021-2026 ($ million)
- Exhibit 33: Data Table on Outer ear infections - Market size and forecast 2021-2026 ($ million)
- Exhibit 34: Chart on Outer ear infections - Year-over-year growth 2021-2026 (%)
- Exhibit 35: Data Table on Outer ear infections - Year-over-year growth 2021-2026 (%)
- 5.5 Inner ear infections - Market size and forecast 2021-2026
- Exhibit 36: Chart on Inner ear infections - Market size and forecast 2021-2026 ($ million)
- Exhibit 37: Data Table on Inner ear infections - Market size and forecast 2021-2026 ($ million)
- Exhibit 38: Chart on Inner ear infections - Year-over-year growth 2021-2026 (%)
- Exhibit 39: Data Table on Inner ear infections - Year-over-year growth 2021-2026 (%)
- 5.6 Market opportunity by Type
- Exhibit 40: Market opportunity by Type ($ million)
6 Customer Landscape
- 6.1 Customer landscape overview
- Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
- 7.1 Geographic segmentation
- Exhibit 42: Chart on Market share by geography 2021-2026 (%)
- Exhibit 43: Data Table on Market share by geography 2021-2026 (%)
- 7.2 Geographic comparison
- Exhibit 44: Chart on Geographic comparison
- Exhibit 45: Data Table on Geographic comparison
- 7.3 North America - Market size and forecast 2021-2026
- Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
- Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
- 7.4 Europe - Market size and forecast 2021-2026
- Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
- Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
- 7.5 Asia - Market size and forecast 2021-2026
- Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
- Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
- 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
- Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- 7.7 US - Market size and forecast 2021-2026
- Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
- Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
- 7.8 Denmark - Market size and forecast 2021-2026
- Exhibit 66: Chart on Denmark - Market size and forecast 2021-2026 ($ million)
- Exhibit 67: Data Table on Denmark - Market size and forecast 2021-2026 ($ million)
- Exhibit 68: Chart on Denmark - Year-over-year growth 2021-2026 (%)
- Exhibit 69: Data Table on Denmark - Year-over-year growth 2021-2026 (%)
- 7.9 China - Market size and forecast 2021-2026
- Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
- Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
- Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
- Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
- 7.10 Canada - Market size and forecast 2021-2026
- Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
- Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
- Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
- Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
- 7.11 India - Market size and forecast 2021-2026
- Exhibit 78: Chart on India - Market size and forecast 2021-2026 ($ million)
- Exhibit 79: Data Table on India - Market size and forecast 2021-2026 ($ million)
- Exhibit 80: Chart on India - Year-over-year growth 2021-2026 (%)
- Exhibit 81: Data Table on India - Year-over-year growth 2021-2026 (%)
- 7.12 Market opportunity by geography
- Exhibit 82: Market opportunity by geography ($ million)
8 Drivers, Challenges, and Trends
- 8.3 Impact of drivers and challenges
- Exhibit 83: Impact of drivers and challenges in 2021 and 2026
9 Vendor Landscape
- 9.2 Vendor landscape
- Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
- 9.3 Landscape disruption
- Exhibit 85: Overview on factors of disruption
- 9.4 Industry risks
- Exhibit 86: Impact of key risks on business
10 Vendor Analysis
- 10.1 Vendors covered
- Exhibit 87: Vendors covered
- 10.2 Market positioning of vendors
- Exhibit 88: Matrix on vendor position and classification
- 10.3 Akorn Inc.
- Exhibit 89: Akorn Inc. - Overview
- Exhibit 90: Akorn Inc. - Product / Service
- Exhibit 91: Akorn Inc. - Key offerings
- 10.4 F. Hoffmann La Roche Ltd.
- Exhibit 92: F. Hoffmann La Roche Ltd. - Overview
- Exhibit 93: F. Hoffmann La Roche Ltd. - Business segments
- Exhibit 94: F. Hoffmann La Roche Ltd. - Key offerings
- Exhibit 95: F. Hoffmann La Roche Ltd. - Segment focus
- 10.5 GlaxoSmithKline Plc
- Exhibit 96: GlaxoSmithKline Plc - Overview
- Exhibit 97: GlaxoSmithKline Plc - Business segments
- Exhibit 98: GlaxoSmithKline Plc - Key news
- Exhibit 99: GlaxoSmithKline Plc - Key offerings
- Exhibit 100: GlaxoSmithKline Plc - Segment focus
- 10.6 Johnson and Johnson
- Exhibit 101: Johnson and Johnson - Overview
- Exhibit 102: Johnson and Johnson - Business segments
- Exhibit 103: Johnson and Johnson - Key news
- Exhibit 104: Johnson and Johnson - Key offerings
- Exhibit 105: Johnson and Johnson - Segment focus
- 10.7 Lupin Ltd.
- Exhibit 106: Lupin Ltd. - Overview
- Exhibit 107: Lupin Ltd. - Product / Service
- Exhibit 108: Lupin Ltd. - Key news
- Exhibit 109: Lupin Ltd. - Key offerings
- 10.8 Novartis AG
- Exhibit 110: Novartis AG - Overview
- Exhibit 111: Novartis AG - Business segments
- Exhibit 112: Novartis AG - Key offerings
- Exhibit 113: Novartis AG - Segment focus
- 10.9 Otonomy Inc.
- Exhibit 114: Otonomy Inc. - Overview
- Exhibit 115: Otonomy Inc. - Product / Service
- Exhibit 116: Otonomy Inc. - Key offerings
- 10.10 Pfizer Inc.
- Exhibit 117: Pfizer Inc. - Overview
- Exhibit 118: Pfizer Inc. - Product / Service
- Exhibit 119: Pfizer Inc. - Key news
- Exhibit 120: Pfizer Inc. - Key offerings
- 10.11 Sensorion
- Exhibit 121: Sensorion - Overview
- Exhibit 122: Sensorion - Product / Service
- Exhibit 123: Sensorion - Key offerings
- 10.12 WraSer Pharmaceuticals
- Exhibit 124: WraSer Pharmaceuticals - Overview
- Exhibit 125: WraSer Pharmaceuticals - Product / Service
- Exhibit 126: WraSer Pharmaceuticals - Key offerings
11 Appendix
- 11.2 Inclusions and exclusions checklist
- Exhibit 127: Inclusions checklist
- Exhibit 128: Exclusions checklist
- 11.3 Currency conversion rates for US$
- Exhibit 129: Currency conversion rates for US$
- 11.4 Research methodology
- Exhibit 130: Research methodology
- Exhibit 131: Validation techniques employed for market sizing
- Exhibit 132: Information sources
- 11.5 List of abbreviations
- Exhibit 133: List of abbreviations
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
SOURCE Technavio
Share this article